Introduction
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in children, and is increasingly recognized as a significant pathogen among the elderly. Although most cases of RSV infection are mild to moderate, severe bronchiolitis, typically in premature infants, in immunocompromised hosts, and even in those with no known risk factors, involves substantial inflammation, with mucus secretion and sloughing of the bronchiolar epithelium, ultimately leading to respiratory compromise (Hall et al., 2009; Krilov, 2011; van Bleek et al., 2011) .
Alveolar macrophages are specialized cells of the respiratory tract, and the predominant leukocyte population at homeostasis; they express unique cell surface antigens, pattern-recognition receptors and immunomodulatory mediators, and function to promote immune surveillance against microbial invasion (Gordon and Read, 2002; Gordon and Taylor, 2004) . Although virus antigens are detectable in alveolar macrophages isolated from RSV-infected human subjects (Midulla et al., 1993) and virions are capable of inducing the synthesis and release of proinflammatory mediators by both human and mouse macrophages in culture (Franke et al., 1994; Franke-Ullmann et al., 1995; Matsuda et al., 1996; Stadnyk et al., 1997; Tsutsumi et al., 1996) the precise contributions of alveolar macrophages to the pathogenesis of RSV disease remain uncertain. For example, in a study performed by Pribul et al. (2008) , RSV-challenged macrophages in BALB/c mice contributed to the early, immediate release of pro-inflammatory cytokines, although macrophage depletion had no impact on RSV-mediated T cell recruitment, weight loss, or lung function. In contrast, Reed et al. (2008) found that macrophage depletion prior to RSV challenge resulted in prominent airway occlusion in association with ongoing disease. Of note, although mouse challenge models have been employed extensively to study RSV disease, standard experimental RSV virus strains replicate minimally in commonlyavailable wild-type experimental mice and ordinarily elicit a limited spectrum of clinical symptoms (Bem et al., 2011; Durbin and Durbin, 2004) .
Pneumonia virus of mice (PVM, strain J3666) is a highly virulent natural rodent pathogen of the same family (Paramyxoviridae) and genus (Pneumovirus) as RSV. First characterized by Horsfall and Curnen (1946) , mice that are inoculated with fewer than 0.1 TCID 50 units respond with robust replication in bronchiolar epithelial cells, and develop severe acute inflammation, which ultimately progresses to respiratory failure and death, with histopathologic findings similar to that of severe RSV infection in human infants (reviewed in Easton et al., 2006; Rosenberg and Domachowske, 2008) .
Here we examine PVM infection in primary macrophage culture and we explore the impact of macrophage ablation on the pathogenesis of and survival in response to acute pneumovirus infection in vivo.
Results and discussion
PVM replicates in mouse macrophages and elicits production of infectious virions and release of proinflammatory cytokines
We previously documented the replication of PVM and production of proinflammatory cytokines in a mouse macrophage cell line (RAW 264.7; Dyer et al., 2007) . Here we examined PVM replication in primary cultures of mouse peritoneal macrophages. Similar to findings with RAW 264.7 cells, virus recovery from infected mouse macrophages increased over time [Figs. 1A and B] . To assess the production and release of infectious virions, supernatants from PVMinfected mouse macrophage cultures were harvested and used to inoculate RAW 264.7 reporter cultures as previously described . Using this method, we detected infectious virions in culture supernatants from PVM-infected peritoneal macrophage cultures on days 5 and 7 after inoculation [ Fig. 1C] . Interestingly, little to no RSV replication was reported in primary mouse macrophage culture (Franke et al., 1994; Franke-Ullmann et al., 1995; Stadnyk et al., 1997) , although Dakhama et al. (1998) identified a minor population of high-density guinea pig alveolar macrophages that supported virion assembly. We also determined that PVM infection induced the expression of transcripts encoding proinflammatory mediators CCL2 and CCL3 in peritoneal macrophage cultures [ Fig. 2A] ; immunoreactive CCL2 and CCL3 were detected in all culture supernatants, but significant expression over background (ie., no virus, heat-inactivated virus inoculations) was detected in response to PVM infection [ Fig. 2B ]. CCL2 and CCL3 contribute significantly to the pathogenesis of acute PVM infection in mice (Bonville et al., 2006; Domachowske et al., 2000) ; we have shown previously that blockade of CCL3 signaling results in dramatic improvements in survival (Bonville et al., 2003 (Bonville et al., , 2004 . Likewise, CCL2 and CCL3 are detected prominently in the airway washings of infants with severe RSV disease (Garofalo et al., 2001; Harrison et al., 1999; McNamara et al., 2005) ; Garofalo et al. (2001) have reported an inverse correlation between levels of CCL2 and CCL3 in the airways and oxygen saturation. ) that has been used successfully in purification strategies (Bedoret et al., 2009; GeurtsvanKessel et al., 2008; Gough and Gordon, 2000) We show here that this approach can also be applied to the isolation of alveolar macrophages from lungs of virus-infected mice, although PVM infection alters the profile of copurifying leukocytes. Specifically, after anti-CD11c magnetic bead selection, the target CD204 wide variety of carbohydrate-bearing ligands (damaged cells, fungi, mycobacteria), and elicits production of proinflammatory cytokines (Miyake et al., 2010) . To the best of our knowledge, this is the first report regarding expression of this molecule in association with pneumovirus infection. Transcripts encoding CD86 were also upregulated, likewise indicative of an activated phenotype. Among the proinflammatory cytokines, we detect augmented expression of transcripts encoding TNF-α, IL-1 and IL-6, and, consistent with our observations from PVMinfected macrophages in culture, we observe prominent expression of Ccl2 and Ccl3 [ Fig. 3H ]. Expression of Cxcl10 increased dramatically, more than 500 fold; other chemokine genes differentially expressed in alveolar macrophages from PVM-infected mice include Ccl5, Ccl17, Cxcl1, Cxcl2 and Cxcl3. Other transcripts expressed alveolar macrophages from PVM-infected mice include IFN-β1 and CXCL11 (data not shown).
Alveolar macrophage depletion results in prolonged survival of PVMinfected mice
PVM-infected mice typically suffer from marked morbidity, weight loss and life-threatening respiratory failure, at least in part in response to the severe, acute inflammatory response (Easton et al., 2006; Rosenberg and Domachowske, 2008) . In order to examine the contribution of alveolar macrophages to the pathogenesis of acute pneumovirus infection, these cells were depleted by intratracheal instillation with clodronate-filled liposomes. As shown in Fig. 4A (also Suppl. Fig. 1 ), intratracheal instillation of clodronate-filled liposomes (Cl 2 -MDP-liposomes) resulted in a 25-fold depletion of alveolar macrophages (CD204 +   CD11c   high   CD11b low cells, as above) from mouse lung tissue within 24 h that persisted for up to 5 days. Instillation of PBS alone or an equivalent number of PBS-liposomes had no impact on the recovery of alveolar macrophages. Mice that received PBS-liposomes as control 24 h prior to virus inoculation succumbed to the negative sequelae of acute PVM infection within 5 to 11 days after inoculation, with a median survival time of 8 days; Fig. 4B ). In contrast, macrophagedepleted mice experience prolonged survival, with a median survival time of 9 days (p b 0.001). Interestingly, we observed a small but statistically significant increase in virus recovery from lung tissue of mice subjected to alveolar macrophage depletion [ Fig. 5A ], similar to results of Pribul et al. (2008) who evaluated macrophage-depleted RSVchallenged BALB/c mice. Although our results seem paradoxical in light of the significantly prolonged survival, we have previously reported that changes in peak virus recovery do not necessarily predict survival (Gabryszewski et al., 2011 pneumovirus infection remains uncertain, relative NK cell deficiency was reported as a feature of severe RSV disease in human infants (De Weerd et al., 1998) ; recently, Kaiko et al. (2010) demonstrated that NK cell depletion of RSV-challenged BALB/c mice resulted in suppression of IFN-γ production and the development Th2 cytokine responses and subsequent allergic lung disease Alveolar macrophage depletion in PVM-infected mice results in augmented expression of interferon-gamma
As a further exploration of the mechanism of differential survival, the impact of alveolar macrophage depletion on the production of inflammatory mediators was evaluated. The most prominent and consistent response was augmented expression of IFNγ in PVM-infected macrophage depleted mice [ Fig. 6A (Maher et al., 2007; Schroder et al., 2004) , the primary role of this cytokine in pneumovirus infection remains unclear (Durbin and Durbin, 2004) . Our findings are consistent with previously published clinical reports, (Aberle et al., 2004; Eisenhut, 2008; Garcia et al., in press; Semple et al., 2007) which suggest a correlation between decreased production of IFNγ and increasing severity of RSV disease. Among studies that have addressed the mechanistic relationship between IFNγ and various outcomes of acute pneumovirus infection, Harker et al. (2010) determined that delivery of IFNγ via a recombinant bicistronic RSV vector results in attenuated virus replication, while Culley et al. (2002) suggested that viral replication and IFNγ-mediated responses may not be directly linked; in this Frey et al. (2008) examined PVM infection in IFNγR genedeleted mice, and determined that receptor-mediated signaling had no impact on virus recovery or infection-associated weight loss. The aforementioned study was carried out in C57BL/6 mice, in contrast to our findings, which were generated in BALB/c mice. Ahn et al. (2006) found that BALB/c mice are substantially more susceptible to PVM infection than C57BL/6 mice. It is possible that IFNγR-mediated signaling contributes to this differential susceptibility; these hypotheses will need to be addressed with further experiments. We have shown previously that IFNγR-mediated signaling is not required to promote seroconversion to PVM antigens, although the actions of this cytokine are crucial for CCL3-mediated neutrophil recruitment (Bonville et al., 2006 (Bonville et al., , 2009 Ellis et al., 2007) . The results featured here suggest that IFNγ may have a protective, immunomodulatory role in PVM infection at least in BALB/c mice, as increased expression, observed in the setting of macrophage depletion, results in prolonged survival despite augmented virus recovery.
Conclusions
We have shown that the natural rodent pneumovirus pathogen, PVM, replicates in primary mouse macrophage culture and induces production and release of infectious virions and proinflammatory cytokines CCL2 and CCL3. Alveolar macrophages isolated from PVMinfected mice express activation markers Clec43 and CD86 as well as numerous proinflammatory cytokines and chemokines. Depletion of alveolar macrophages by intratracheal instillation with clodronatefilled liposomes results in small but statistically significant increases in virus recovery, but, paradoxically, prolonged survival in response to PVM infection. Alveolar macrophage depletion resulted in an increase in NK cell recruitment, but had no impact on the recruitment of granulocytes, CD4 + Taken together, these results suggest that macrophage-depletion results in augmented production of IFNγ from multiple sources, uncovering a potential protective, immunomodulatory functions of this pleiotropic cytokine in primary pneumovirus infection.
Materials and methods

Mouse and virus stocks
6-8 week old BALB/c mice were purchased from Division of Cancer Therapeutics (DCT, National Cancer Institute, National Institutes of Health). All procedures were reviewed and approved according to Animal Study Protocol LAD8E, approved by the National Institute of Allergy and Infectious Diseases (NIAID) Animal Care and Use Committee. Mouse-passaged PVM strain J3666 was used in all experiments. Virus copy number in stocks and inocula were evaluated by qRT-PCR targeting the unique SH gene as previously described (Gabryszewski et al., 2011) . Prior to inoculation of cells in culture, clarified lung homogenates were dialyzed at 4°C overnight against phosphate buffered saline (50 kDa MW cut off dialysis tubing, Spectrum Laboratories).
Cell culture
Isolated alveolar and peritoneal macrophages were cultured in DMEM/F12 supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 units/mL penicillin, 100 μg/mL streptomycin and 100 IU/mL M-CSF (R&D Systems). RAW 264.7 cells (ATCC TIB-71; ATCC) were maintained in IMDM supplemented with 10% FBS, 2 mM L-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin.
Isolation of peritoneal macrophages and challenge with PVM
Peritoneal cavities of naive mice were lavaged with RPMI 1640 supplemented with 10% FBS, 2 mM L-glutamine, 100 units/mL penicillin, 100 μg/mL streptomycin and 25 μM 2-mercaptoethanol. Peritoneal fluids were pooled and centrifuged (400×g, 5 min). Pelleted cells were suspended in DMEM/F12 supplemented with 10% FBS, 2 mM L-glutamine, 100 units/mL penicillin, 100 μg/mL streptomycin and 100 IU/mL M-CSF and seeded in culture plates. Cells were permitted to adhere to the plates for 40 min prior to washing with PBS. Routinely, more than 90% of the cells obtained by this procedure displayed a macrophage phenotype as assessed by visual inspection and by anti-F4/80 staining. Peritoneal macrophages were challenged 24 h later with PVM, heat-inactivated PVM ( hi PVM; PVM virions heated to 95°C and then flash frozen in a dry icemethanol bath, repeated 3 times) at a multiplicity of infection (MOI) of 100 or were sham treated with an equal volume of IMDM. The cells and virus were co-incubated for 4 h at 37°C in a humidified 5% CO 2 incubator, after which the cells were washed twice with PBS and placed in fresh complete medium. At the time points indicated, aliquots of culture media were collected for analysis of virus recovery by qRT-PCR, cytokine release by ELISA (R&D Systems), or Western blot probed with anti-PVM N antibody and anti-beta actin to determine relative loading (Cell Signaling, Millipore Corporation).
Determination of virus recovery
Mouse lung tissues were stored in RNAlater (Ambion) overnight at 4°C prior to RNA extraction. RNA was isolated from lungs with RNAzol Bee reagent (Tel-Test) according to manufacturer's instructions. Virus titer was determined by quantitative RT-PCR with two standard curves (PVM SH gene and cellular GAPDH) as previously described (Gabryszewski et al., 2011) . Western blot was carried out by standard procedures. PVM anti-N antibody was characterized as described in Percopo et al. (2011) .
Release of infectious virions released by cultured macrophages
Supernatants from infected macrophage cultures were collected at the time points indicated and stored at −80°C until use. Aliquots of these culture supernatants (100 μL) were used to inoculate RAW 264.7 reporter cultures seeded in 900 μL of medium. After 7 days, total cellular RNA was isolated, and virus recovery was determined by qRT-PCR.
Isolation and identification of leukocytes from lungs of PVM-infected mice
Mice were anesthetized by a brief inoculation of 20% (v/v) halothane (Ayerst Laboratories) diluted in mineral oil. Anesthetized mice were inoculated intranasally with 5 × 10 5 copies of PVM strain J3666 in IMDM or IMDM as control. Five or six days after inoculation, mice were sacrificed. A PBS solution supplemented with 10 mM EDTA was injected into the heart to perfuse lung tissues. Collected lungs were finely chopped with a razor blade and digested in RPMI containing 5% FBS, 2 mg/mL collagenase D (Roche Diagnostics) and 20 μg/mL grade II DNase I (Roche Diagnostics). After 45 min incubation at 37°C under stirring, 1 volume of fresh digestion medium was added; 10 mM EDTA was added after a total of 90 min digestion time and the lung digest was placed on ice for 5 min. The cell suspension was strained onto a 70 μm nylon mesh and centrifuged (400 ×g, 5 min, 4°C). Red cells were lysed with ACK buffer and remaining cells were washed in PBS containing 2% FBS and 20 μg/mL grade II DNase I. Lung cells were stained with LIVE/DEAD Fixable Near IR stain (Invitrogen) in PBS (30 min, 4°C). To assess neutrophils and eosinophil recruitment to the lung, cells were then probed with anti-mouse GR-1V450 (BD Biosciences), CD11c Alexa 488 (eBioscience), Siglec-F PE (BD Biosciences), CD45 PE-Cy5 (BD Biosciences) in HBSS containing 10 mM EDTA, 10% FBS in the presence of blocking anti-mouse CD16/CD32 (eBioscience) for 20 min at 4°C. To assess T cell and NK cell recruitment, fluorochrome-coupled antibodies included anti-mouse CD3 FITC (BD Biosciences), CD8 PE (BD Biosciences), CD4 PerCp-Cy5.5 (eBioscience) and DX5 PE-Cy7 (BD Biosciences). To enumerate alveolar macrophages, cells were probed with anti-mouse CD11c Alexa 488 (eBioscience), CD11b PE (BD Biosciences) and CD204 Alexa 647 (AbD Serotec). Parallel samples were stained with isotype-matched controls replacing the aforementioned specific mAbs. Antibody-bound cells were washed twice in HBSS supplemented with 10 mM EDTA and 10% FBS and analyzed by flow cytometry (LSRII, BD Biosciences).
Purification of alveolar macrophages
Lung cell suspensions were prepared as described above; CD11c Relative expression of proinflammatory cytokines in alveolar macrophages from PVM-infected mice RNA was isolated from sorted alveolar macrophages from both control and PVM-infected mice using the RT 2 qPCR-grade RNA Isolation Kit (SA Biosciences, Frederick, MD). First-strand cDNA was generated using the RT 2 First-strand Kit (SA Biosciences) and, in conjunction with the RT 2 SYBR Green/ROX qPCR Master Mix (SABiosciences), analyzed for differential gene expression using the RT 2 Profiler Toll-Like Receptor
Signaling Pathway PCR Array and the Inflammatory Response and Autoimmunity PCR Array (SA Biosciences). Alternatively, sorted alveolar macrophages were seeded in macrophage complete medium (see above). Alveolar macrophage supernatants were aliquoted at specified time points and tested for cytokine production by multiplex bead array (BioRad) or ELISA (R&D Systems).
Depletion of alveolar macrophages
Clodronate (dichloromethylene diphosphonate, Cl 2 MDP) or PBS encapsulated liposomes (Encapsula Nanosciences) were injected intratracheally. (60 μL, 1:2 dilution in PBS) to each anesthetized naive recipient. Anesthesia was achieved by injecting 80 μL of 2 mg/mL xylazine, 12.5 mg/mL ketamine in PBS via the intraperitoneal route. Twentyfour hrs later, mice were infected with 1 × 10 5 copies of PVM strain J3666 after inhalation anesthesia with 20% (v/v) halothane (Ayerst Laboratories) in mineral oil. Mouse survival was evaluated every 24 h. Whole lung tissue was stored in RNAlater (Ambion) for determination of virus recovery, or blade-homogenized in ice-cold PBS-BSA 0.01% (w/v), followed by centrifugation (2000 ×g, 15 min, 4°C) for preparation of clarified tissue homogenates. Clarified supernatants were stored in aliquots at −80°C until use. Cytokine concentration was determined by ELISA (R&D Systems). Datapoints were normalized to total protein content, which was measured by micro BCA protein essay (Pierce Biotech).
Intracellular cytokine staining
Intracellular cytokine staining was performed according to previously published methods (Foster et al., 2007) . Cells were washed twice and resuspended in RPMI 1640 medium supplemented with 5% FBS, 100 U/ ml penicillin, 100 μg/mL streptomycin and 1 mM L-glutamine. Cells were sham-stimulated or stimulated with 20 ng/mL phorbol myristate acetate and 1 μM ionomycin in the presence of 10 μg/mL brefeldin A. Stimulation was performed in 16-mm × 125-mm culture tubes (Corning, 4 × 10 6 cells, 2 mL, 37°C) with gentle stirring. After 4 h, the samples were washed twice in cold PBS, labeled with LIVE/DEAD Fixable Violet Dead Cell Stain (Invitrogen) according to the manufacturer's instructions, washed in cold PBS, and stained with mAb diluted in PBS containing 10 mM EDTA, 10% FBS in the presence of blocking anti-mouse CD16/ CD32 (eBioscience) for 20 min at 4°C. The following 5-color panel was used: Violet LIVE/DEAD in combination with anti-mouse CD3 FITC (BD Biosciences), CD8 PE (BD Biosciences), CD4 PerCp-Cy5.5 (eBioscience) and DX5 PE-Cy7 (BD Biosciences). Cells were washed twice in cold PBS, fixed in 4% paraformaldehyde (Sigma), washed in PBS and stored 16 h at 4°C. For intracellular staining, cells were blocked in PBS with 0.1% saponin and 5% nonfat dried milk for 60 min and stained thereafter with antimouse IFNγ APC diluted in PBS/saponin/nonfat dried milk for 30 min. Stained cells were washed twice with PBS, and resuspended in PBS with 0.1% BSA (w/v) for analysis. Parallel samples were stained with isotype-matched controls replacing the anti-mAbs.
Statistical analysis
All data points indicate the average of samples ± SEM. All analyses were performed using GraphPad Prism 5 (GraphPad). Log-rank test was used in survival studies. In other cases, statistical significance was determined by an ANOVA test, followed by a Bonferroni test for comparison between groups. Significant outliers were excluded by using Grubbs test. All experiments were repeated at least 2 times to confirm results.
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